Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Back to Journals Diabetes, Metabolic Syndrome and Obesity Volume 12 Oral Semaglutide In The Management Of Type 2 Diabetes: A Report On The Evidence To Date Authors Pearson S , Kietsiriroje N , Ajjan RA Received 4 September 2019 Accepted for publication 8 November 2019 Published 2 December 2019 Volume 2019:12 Pages 25152529 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Professor Ming-Hui Zou Sam Pearson, 1, * Noppadol Kietsiriroje, 1, 2, * Ramzi A Ajjan 1 1 Leeds Institute of Cardiovascular and Metabolic Medicine, Faculty of Medicine and Health, University of Leeds, Leeds, West Yorkshire LS2 9JT, UK
Genome medicine , 4 (8), 67
it is available through channels labelled strictly for research purposes
Understanding which form youre taking clears up most of the confusion
PMID: 37727016
(2021) 11:e043054
US$ 28.55
US$ 21.09
US$ 26.65
US$ 21.57
US$ 24.04
US$ 26.55
US$ 20.59
US$ 26.36
